Clinical Trials Directory

Trials / Completed

CompletedNCT00685490

Vitrectomy for Branch Retinal Vein Occlusion

Vitrectomy for Persistent Macular Edema in Branch Retinal Vein Occlusion

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Shinjo Ophthalmologic Institute · Academic / Other
Sex
All
Age
45 Years – 86 Years
Healthy volunteers
Not accepted

Summary

To evaluate the long term outcomes of pars plana vitrectomy (PPV), with and without internal limiting membrane (ILM) peeling, in eyes with persistent macular edema secondary to branch retinal vein occlusion (BRVO). Results suggest the following hypothesis: * PPV, with and without ILM peeling, appears to be beneficial in eyes with persistent macular edema due to BRVO * Effectiveness is maintained long term * ILM peeling does not significantly affect postoperative best corrected visual acuity (BCVA)

Conditions

Interventions

TypeNameDescription
PROCEDUREVitrectomy w/o ILM peeling for macular edema with BRVOConcurrent phacoemulsification and intraocular lens insertion in the capsular bag was performed, followed by PPV with separation of the posterior hyaloid from the optic disk and posterior retina with a posterior vitreous detachment was not present. Indocyanine green (ICG)-assisted peeling was performed in all consecutive patients between April 2000 and June 2003. 0.1% ICG solution was injected over the macular region. Immediately after application, the dye was washed out using a vitreous cutter. Repeated injection of ICG was not required. Triamcinolone acetonide (TA)-assisted ILM peeling was performed in all consecutive patients from July 2003 to November 2006.

Timeline

Start date
1995-07-01
Completion
2006-11-01
First posted
2008-05-28
Last updated
2008-05-28

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00685490. Inclusion in this directory is not an endorsement.

Vitrectomy for Branch Retinal Vein Occlusion (NCT00685490) · Clinical Trials Directory